P0382 : Angiotensin II type 1 receptor antagonists as adjuvant therapy for hepatocellular carcinoma patients treated with radiofrequency ablation

2015 ◽  
Vol 62 ◽  
pp. S455-S456
Author(s):  
A. Facciorusso ◽  
V. Del Prete ◽  
N. Crucinio ◽  
A. Di Leo ◽  
M. Barone
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Angiotensin Ii ◽  
Adjuvant Therapy ◽  
Receptor Antagonists

Angiotensin II type 1 receptor antagonists prevent glucose‐induced increases in islet blood flow in rats

2009 ◽  
Vol 69 (1) ◽  
pp. 145-150 ◽  
Author(s):  
Masanori Iwase ◽  
Yuji Uchizono ◽  
Sakae Nohara ◽  
Nobuhiro Sasaki ◽  
Kazuo Sonoki ◽  
...  
Keyword(s):  
Blood Flow ◽  
Angiotensin Ii ◽  
Receptor Antagonists ◽  
Islet Blood Flow

Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists

2002 ◽  
Vol 59 (3) ◽  
pp. 344-348 ◽  
Author(s):  
Hüseyin Abali ◽  
Ibrahim H Güllü ◽  
Hüseyin Engin ◽  
Ibrahim C Haznedaroğlu ◽  
Mustafa Erman ◽  
...  
Keyword(s):  
Angiotensin Ii ◽  
Enzyme Inhibitors ◽  
Converting Enzyme ◽  
Angiotensin I ◽  
Receptor Antagonists ◽  
Converting Enzyme Inhibitors ◽  
Angiotensin I Converting Enzyme

Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer

2013 ◽  
Vol 328 (2) ◽  
pp. 318-324 ◽  
Author(s):  
Xuesong Chen ◽  
Qingwei Meng ◽  
Yanbin Zhao ◽  
Meiyan Liu ◽  
Dandan Li ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cell Proliferation ◽  
Angiotensin Ii ◽  
Receptor Antagonists ◽  
Inhibit Cell Proliferation
Sign in / Sign up

Export Citation Format

Share Document